Gregory Glenn
Equibles does not estimate personal net worth.
About Gregory Glenn
Novavax Inc reported in an 8-K filed March 22, 2023 that Gregory Glenn retired as President, Research and Development, effective March 31, 2023. Novavax Inc reported in an 8-K filed March 2, 2023 that Gregory Glenn retired as President, Research and Development, effective March 31, 2023. The proxy statement of Novavax Inc reports total compensation of $4,093,686 for Gregory Glenn in fiscal 2022, including a base salary of $593,750. Disclosed compensation is on record for 6 fiscal years.
“on February 28, 2023, Dr. Gregory M. Glenn, M.D. notified Novavax Inc. (the “Company”) of his decision to retire as President, Research and Development, effective as of March 31, 2023.”
“On February 28, 2023, Dr. Gregory M. Glenn, M.D. notified Novavax Inc. (the "Company") of his decision to retire as President, Research and Development, effective as of March 31, 2023.”
Affiliation history
-
Novavax Inc (NVAX)
Proxy statement
Start not stated–2023-03-31
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Novavax Inc (NVAX) | Former President, Research and Development | $593,750 | $4,093,686 |
| 2021 | Novavax Inc (NVAX) | Former President, Research and Development | $553,000 | $813,444 |
| 2020 | Novavax Inc (NVAX) | Former President, Research and Development | $483,443 | $24,923,376 |
| 2019 | Novavax Inc (NVAX) | President, Research and Development | $470,453 | $1,875,198 |
| 2018 | Novavax Inc (NVAX) | President, Research and Development | $460,125 | $1,681,456 |
| 2017 | Novavax Inc (NVAX) | President, Research and Development | $450,000 | $1,221,250 |